Revenue Recognition - Summary of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Net Revenue	$ 28,316	$ 23,771	$ 76,824	$ 61,519
Drug products
Disaggregation of Revenue [Line Items]
Net Revenue	11	2,197	34	2,327
Concentrate Products
Disaggregation of Revenue [Line Items]
Net Revenue	28,305	21,574	76,790	59,192
U.S.
Disaggregation of Revenue [Line Items]
Net Revenue	26,247	19,741	70,390	53,798
U.S. | Drug products
Disaggregation of Revenue [Line Items]
Net Revenue	0	0	0	0
U.S. | Concentrate Products
Disaggregation of Revenue [Line Items]
Net Revenue	26,247	19,741	70,390	53,798
Rest of World
Disaggregation of Revenue [Line Items]
Net Revenue	2,069	4,030	6,434	7,721
Rest of World | Drug products
Disaggregation of Revenue [Line Items]
Net Revenue	11	2,197	34	2,327
Rest of World | Concentrate Products
Disaggregation of Revenue [Line Items]
Net Revenue	2,058	1,833	6,400	5,394
License Fee – Over time | Drug products
Disaggregation of Revenue [Line Items]
Net Revenue	11	2,197	34	2,327
License Fee – Over time | Concentrate Products
Disaggregation of Revenue [Line Items]
Net Revenue		0		1,472
License Fee – Over time | U.S. | Drug products
Disaggregation of Revenue [Line Items]
Net Revenue	0	0	0	0
License Fee – Over time | U.S. | Concentrate Products
Disaggregation of Revenue [Line Items]
Net Revenue		0		1,472
License Fee – Over time | Rest of World | Drug products
Disaggregation of Revenue [Line Items]
Net Revenue	11	2,197	34	2,327
License Fee – Over time | Rest of World | Concentrate Products
Disaggregation of Revenue [Line Items]
Net Revenue		0		0
Product Sales – Point-in-time | Concentrate Products
Disaggregation of Revenue [Line Items]
Net Revenue	28,305	21,574	76,790	57,720
Product Sales – Point-in-time | U.S. | Concentrate Products
Disaggregation of Revenue [Line Items]
Net Revenue	26,247	19,741	70,390	52,326
Product Sales – Point-in-time | Rest of World | Concentrate Products
Disaggregation of Revenue [Line Items]
Net Revenue	$ 2,058	$ 1,833	$ 6,400	$ 5,394